ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2013 American Transplant Congress

May 18-22, 2013 in Seattle, Washington

Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z
  • Identification of Common Blood-Based Biomarker Gene Panels for the Diagnosis of Renal and Cardiac Acute Allograft Rejection

    S. Roedder, L. Li, K. Kush, S. Hsieh, H. Luikart, A. Yang, H. Valentine, M. Sarwal

  • Identification of EBV-Specific CXCR3+/CXCR5+ CD8+T Cells in Peripheral Blood of Asymptomatic Pediatric Heart Transplant Recipients Who Carry EBV Loads

    C. Macedo, T. Shipley, K. Hadi, A. Norlander, J. Luce, B. Feingold, S. Webber, D. Metes

  • Identification of Independent Risk Factors for De Novo DSA Development through Prospective Monitoring

    J. DeVos, R. Knight, S. Patel, G. Land, E. Graviss, L. Teeter, A. Gaber

  • Identification of Urinary Biomarkers during Antibody-Mediated Rejection in a Murine Kidney Transplant Model

    T. Abe, K. Keslar, F. Ran, C. Su, S. Iida, W. Baldwin III, N. Nonomura, S. Takahara, R. Fairchild

  • Identifying the Most Dangerous DSA: A 12-Year Longitudinal Post-Transplant Study of IgM, IgG, and IgG Isotype HLA Alloantibodies in Primary Renal Transplant Recipients

    M. Everly, L. Rebellato, K. Briley, C. Morgan, P. Bolin, W. Kendrick, S. Kendrick, C. Haisch, R. Harland, P. Terasaki

  • IGL-1 Solution Prevents Proteolysis during Cold Steatotic Liver Graft Preservation

    M. Zaouali, M. Bejaoui, J. Garcia, A. Ribes, E. Pantazi, E. Folch, H. Abdennebi, J. Roselló-Catafau

  • IL-1 Receptor Antagonist Treatment Rescues Impact of Brain Death Related Inflammation in Liver of Non-Human Primates

    L. Zitur, J. Danobeitia, J. Sperger, M. Hanson, E. Park, P. Chlebeck, L. Fernandez

  • IL-1β Polymorphism Increase Susceptibility to Invasive Mold Infection after Solid Organ Transplantation (SOT)

    A. Wójtowicz, T. Lecompte, S. Bibert, O. Manuel, C. Berger, K. Boggian, C. Garzoni, H. Hirsch, M. Weisser, N. Mueller, P. Meylan, M. Pascual, C. Van Delden, P. Bochud, the Swiss Transplant Cohort Study (STCS)

  • IL-2 Antagonist Induction Therapy Preserves Renal Function in Liver Transplant Recipients

    A. Mardis, H. Meadows, D. Taber, N. Pilch, J. Fleming, C. Jordan, K. Morbitzer, C. Makowski, J. McGillicuddy, C. Bratton, K. Chavin, P. Baliga

  • IL-21R+ Marginal Zone Precursor (MZP) B Cells in the Germinal Center Induce IL-10 Dependent Allogeneic Tolerance

    G. Lal, Y. Nakayama, A. Sethi, A. Singh, B. Burrell, N. Kulkarni, C. Brinkman, D. Iwami, J. Bromberg

  • IL-33 Expands ST2+ Regulatory T Cells Promoting Allograft Survival Directly and Indirectly through Actions on Myeloid Dendritic Cells

    B. Matta, L. Mathews, B. Rosborough, H. Turnquist

  • IL-33 Receptor Expression by Cardiac and Aortic Allografts Limits Immune Infiltration and Development of Vasculopathy

    Q. Liu, H. Turnquist

  • IL-33: Friend or Foe?

    D. Abendroth, M. Marzinzig, M. Stangl

  • IL21 Plays a Critical Role in Chronic Rejection but Not in Acute or Accelerated Allograft Rejection

    P. Schroder, M. Khattar, C. Baum, W. Chen, S. Stepkowski

  • IL28B Polymorphisms Influence Cytomegalovirus Viremia in Solid Organ Transplant Recipients

    O. Manuel, A. Wójtowicz, S. Bibert, G. Kralidis, A. Egli, N. Mueller, H. Hirsch, J. Steiger, C. Garzoni, I. Binet, C. Berger, M. Weisser, C. Van Delden, A. Humar, M. Pascual, P. Meylan, P. Bochud, the STCS

  • IL37 Controls IL18 Induced Pro-Inflammatory Cytokine Expression by Tubular Cells and Attenuates Renal Ischemia-Reperfusion Injury

    Y. Yang, Z. Yin, S. Ma, Z. Zhang, A. Jevnikar

  • Ileal FGF15/19 to Hepatocyte FGFR4 Axis Is a Novel Positive Regulator of Liver Regeneration after Partial Hepatectomy in Mice

    Z. Guo, Q. Li, X. Zhu, X. He

  • Immediate Extubation Following Pediatric Liver Transplantation: A Single Center Experience

    N. Fullington, R. Cauley, K. Potanos, C. Seefelder, H. Kim, K. Vakili

  • Immune Cell Derived C3a and C5a Mediate Human Alloreactive T Cell Immunity

    P. Cravedi, J. Leventhal, P. Lakhani, P. Heeger

  • Immune Regulation by Fibroblastic Reticular Cells in Tolerance Involves CD40-CD40L Costimulatory Interactions

    Y. Nakayama, B. Burrell, J. Bromberg

  • Immune Suppressant Effect of Erythropoietin Alpha on Human Allo-Reactive T Cell Responses

    J. Manrique, P. Cravedi, P. Heeger, A. Mehrotra

  • Immune Tolerance across a Full MHC Barrier in a Swine Hind Limb Transplantation Model Using a Combined Co-Stimulatory Blockade and Donor Bone Marrow Cells Approach

    A. Leto Barone, Z. Ibrahim, L. Wu, G. Furtmueller, K. Sarhane, M. Alrakan, J. Pang, S. Zhu, J. Christensen, E. Wimmers, S. Schneeberger, D. Cooney, J. Shores, S. Bonawitz, J. Sacks, W. Lee, G. Brandacher

  • Immune, Inflammatory and Apoptosis Gene Expression in Human Formalin-Fixed Paraffin-Embedded (FFPE) Kidney Biopsies Correlate with Banff Scored Acute Rejection and Reveals Heterogeneous Genetic Subtypes Bearing Common Histological Patterns

    P. Ruiz, E. Margolles-Clark, J. Sageshima, G. Ciancio, L. Chen, A. Mattiazi, G. Guerra, W. Kupin, D. Roth, G. Burke

  • Immunologic Outcomes in Clinical Face Transplantation with Large Volume Vascularized Bone Marrow Component

    R. Barth, P. Brazio, D. Klassen, B. Bojovic, D. Kukuruga, C. Drachenberg, S. Bartlett, E. Rodriguez

  • Immunologically Modified FETs for Protein Detection in Biologic Fluids

    A. Theiss, Y. Wang, P. Casal, S. Lee, G. Hadley, J. Von Visger, W. Lu, L. Brillson, N. Singh

  • Immunomodulatory Role of IL-22 in Mouse Liver Ischemia and Reperfusion Injury (IRI): Enhancement of Autophagy by STAT3–c-myc Signaling, The

    Y. Zhang, H. Ji, Y. Liu, X. Shen, F. Gao, C. Fong, R. Busuttil, J. Kupiec-Weglinski

  • Immunophenotyping and Targeting of Plasma Cells in Sensitized Nonhuman Primates

    E. Page, J. Kwun, A. Gibby, S. Knechtle, N. Iwakoshi

  • Immunoregulatory Effects of Bone Marrow and Adipose Derived Stem Cells – An In Vitro Comparison

    L. Wu, N. Yuan, J. Christensen, Z. Ibrahim, G. Furtmüller, A. Leto Barone, S. Zhu, S. Schneeberger, W. Lee, D. Cooney, G. Brandacher

  • Immunosuppression after Renal Allograft Failure: A Survey of US Practices

    G. Bayliss, R. Gohh, P. Morrissey, J. Rodrigue, D. Mandelbrot

  • Immunosuppression Regimen and the Risk of Acute Rejection in HIV-Infected Kidney Transplant Recipients

    J. Locke, N. James, S. Mehta, P. Pappas, R. Mannon, N. Desai, R. Montgomery, D. Segev

  • Immunosuppressive Property of Liver Sinusoidal Endothelial Cells Is Impaired in Small-for-Size Grafts and Restored by Attenuating Portal Hypertension, The

    S. Hashimoto, T. Onoe, Y. Tanaka, Y. Igarashi, H. Ohdan

  • Impact of Anatomical Variations and Insufficient Liver Volume on Living Liver Donation, The

    W. Al-hamoudi, N. Allam, H. Elsiesy, A. Hashim, B. Hegab, Y. El-Sheikh, M. Al-sofayan, H. Albahili, D. Broering, M. Al sebayel, F. Abaalkhail

  • Impact of Anti-HLA Donor Specific Antibodies (DSA) in the Survival and Function of Renal Graft

    L. de Carvalho, O. Machado, D. Seelig, T. Michelon, A. dos Santos, J. Goldani, V. Garcia, J. Neumann, R. Bruno, E. Keitel

  • Impact of Antiviral Preventive Strategies on the Incidence and Outcomes of Cytomegalovirus Disease in Solid-Organ Transplant Recipients

    O. Manuel, G. Kralidis, N. Mueller, H. Hirsch, C. Garzoni, C. Van Delden, C. Berger, K. Boggian, A. Cusini, M. Koller, M. Weisser, M. Pascual, P. Meylan, the STCS

  • Impact of Carbapenem Resistance in Klebsiella pneumoniae Blood Stream Infection in Solid Organ Transplantation

    E. Cober, K. Brizendine, S. Richter, C. Koval, D. Van Duin

  • Impact of Changing Patterns in Deceased Donor Cause of Death on Organs Transplanted Per Donor

    L. Edwards, J. Rosendale

  • Impact of Cholecalciferol Repletion on Alloreactivity in Vitamin D-Deficient Hemodialysis Patients: A Randomized Controlled Trial

    L. Li, M. Lin, P. Heeger, A. Mehrotra

  • Impact of CMS CoP on Kidney Transplant Waiting Times, The

    K. Schnier, C. McIntyre, R. Ruhil, V. Sadiraj, J. Cox, T. Pearson, A. Kirk, N. Turgeon

  • Impact of CMS CoP on the Selection of Patients and Donor Organs, The

    K. Schnier, V. Sadiraj, J. Cox, N. Turgeon

  • Impact of De Novo IgG3 DSA in Graft Survival after Liver Transplantation

    H. Kaneku, J. O'Leary, N. Bañuelos, L. Jennings, B. Susskind, G. Klintmalm, P. Terasaki

  • Impact of Deceased Donor Intensive Care Unit Management Parameters on Early Liver Graft Function

    G. Marshall, R. Mangus, A. Tector

  • Impact of Deceased Donor Kidney Risk Significantly Varies by Recipient Characteristics, The

    E. Heaphy, D. Goldfarb, E. Poggio, L. Buccini, S. Flechner, J. Schold

  • Impact of Delayed Graft Function (DGF) and KDRI on Kidney Graft Survival in HIV (+) Transplant Recipients (HIV KTx)

    G. Malat, K. Ranganna, S. Guy, G. Xiao, D. Reich, A. Doyle

  • Impact of Disease Duration on Islet Yield for Clinical Islet Autotransplants for Chronic Panreatitis

    M. Takita, R. Shahbazov, M. Kanak, F. Kunnathodi, M. Lawrence, N. Onaca, M. Levy, B. Naziruddin

  • Impact of Donor Age on Three-Year Outcomes in Recipients of Extended Criteria Kidneys Treated with Belatacept vs Cyclosporine in BENEFIT-EXT Trial

    K. Budde, J. Morales, G. Blancho, F. Muehlbacher, F. Lehner, K. Rice, L. Pupim, S. Aigner, F. Vincenti

  • Impact of Donor and Recipient Pretransplant EBV Antibody Status on PTLD Incidence in Adult Kidney Transplant Recipients

    N. Chandolias, K. Gillingham, H. Balfour, Jr, A. Matas

  • Impact of Donor HLA Mismatch Grade on Recipient HLA Locus-Specific Sensitisation in Patients Returning to the Kidney Transplant Waiting List Following a Failed Primary Kidney Allograft

    O. Gjorgjimajkoska, C. Taylor, L. Sharples, N. Chatzizacharias, S. Peacock, C. Morgan, E. Bolton, J. Bradley, V. Kosmoliaptsis

  • Impact of Donor Hypoxemia and Hypotension in DCD Liver Transplantation

    K. Kishiyama, R. Girlanda, C. Desai, K. Shetty, J. Laurin, R. Satoskar, E. Island, C. Matsumoto, T. Fishbein

  • Impact of Donor Kidney Disease on Outcomes Following Deceased Donor Kidney Transplantation

    V. Kosmoliaptsis, M. Salji, V. Bardsley, M. Finlay, H. Copley, M. Griffiths, J. Bradley, G. Pettigrew

  • Impact of Donor-Specific Anti-HLA and Anti-Angiotensin-II Type 1 Receptor Antibodies on Graft Fibrosis after Immunosuppression Withdrawal in Pediatric Liver Transplantation

    H. Oe, Y. Uchida, A. Yoshizawa, H. Hirao, M. Taniguchi, E. Maruya, T. Maekawa, S. Uemoto, P. Terasaki

  • Impact of Gamma Chain Cytokines on Cytotoxic T Lymphocyte Function for the Treatment of Viral Infections

    M. Schmueck, S. Sarmadi, B. Weist, N. Babel, H. Volk, P. Reinke

  • Impact of Gender and Body Mass Index on Alanin Aminotransferase Levels in Living Liver Donors with Biopsy Proven Normal Hisotology

    A. Hashim, F. Abaalkhail, H. Elsiesy, M. Alsebayel, W. Alhamoudi

  • Impact of Genetic Polymorphisms of FcγRIIa, FcγRIIIa and C1qA on Infectious Complications after Liver Transplantation, The

    S. Shimizu, H. Tazawa, Y. Tanaka, S. Verma, L. Das, H. Ohdan

  • Impact of Graft Implantation Order on Short- and Long-Term Graft Survival in Simultaneous Pancreas-Kidney Transplants, The

    N. Niclauss, B. Bédat, A. Andres, C. Toso, P. Morel, T. Berney

  • Impact of HLA Mismatching on Sensitization Rates and Subsequent Re-Transplant after First Graft Failure in Pediatric Renal Transplant Recipients, The

    J. Gralla, S. Tong, A. Wiseman

  • Impact of HLA-DQ Matching on Alloantibody Production in Primary Renal Transplant Recipients, The

    M. Everly, L. Rebellato, K. Briley, C. Morgan, P. Bolin, W. Kendrick, S. Kendrick, C. Haisch, R. Harland, P. Terasaki

  • Impact of Hyperuricemia on Outcomes of Kidney Transplantation: Analysis of the FAVORIT (Folic Acid for Vascular Outcome Reduction in Transplantation) Trial, The

    R. Kalil, S. Campbell, M. Carpenter, M. Weir, T. Pesavento, M. Pfeffer, S. Solomon, W. Haynes, L. Hunsicker

  • Impact of Immunosenescence on Bone Marrow Transplantation (BMT) and Chimerism, The

    K. Hock, R. Oberhuper, Y. Lee, T. Wekerle, S. Tullius

  • Impact of Immunosuppression Maintenance after Failed Kidney Transplant on Panel Reactive Antibody (PRA) for Retransplantation, a Single Center Experience

    Q. Ren, M. Behnke, T. Gehr, M. Posner, A. King

  • Impact of Implantation of Ventricular Assist Devices on the Incidence of Post-Transplant Infections in Heart Transplant Recipients

    D. Zbinden, G. Kralidis, T. Carrel, A. Cusini, R. Hullin, P. Meylan, P. Mohacsi, N. Mueller, M. Pascual, F. Ruschitzka, P. Tozzi, C. Van Delden, M. Weisser, M. Wilhelm, O. Manuel, the STCS

  • Impact of Induction Agent on Repeat Kidney Transplant Outcomes in Patients on Maintenance Immunosuppression

    N. Wilson, W. Manitpisitkul, M. Jason, B. Noell, M. Weir, S. Bartlett, J. Bromberg, A. Haririan

  • Impact of Induction Therapy on Clinical Outcomes and Quality of Life in Aged Kidney Transplant Recipients, The

    D. Taber, C. Bratton, A. Al Manasra, N. Pilch, H. Meadows, J. McGillicuddy, K. Chavin, P. Baliga

  • Impact of Intravenous Immunoglobulins on Anti-HLA Immunization after Renal Allograft Nephrectomy

    C. Leibler-Romand, M. Matignon, F. Roudot-Thoraval, L. Salomon, D. Charron, P. Lang, C. Jacquelinet, C. Suberbielle, P. Grimbert

  • Impact of Locoregional Treatment and Waiting Times in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma, The

    J. Lohlun, P. Mahawithitwong, D. Radosevich, S. Chinnakotla, T. Pruett

  • Impact of Long-Term Pretransplant Dialysis Was Not Noted on the Survival of Renal Grafts from DCD Donors

    M. Takenaka, M. Kusaka, H. Sasaki, Y. Kubota, N. Fukami, R. Shiroki, T. Kenmochi, K. Hoshinaga

  • Impact of Matching Frequency in Kidney Paired Donation

    I. Ashlagi, R. Anderson, D. Gamarnik, G. Hil, M. Melcher, A. Roth

  • Impact of mTOR and Calcineurin Inhibition on Lipid and Glucose Metabolism – 24 Month Assessment in De Novo Liver Transplant Recipients Treated with Everolimus and Tacrolimus

    L. Fischer, P. De Simone, F. Saliba, J. Fung, G. Dong, P. Lopez, S. Kohler, G. Junge

  • Impact of Paired Exchange on Living Donor Kidney Transplantation: A Center Level Analysis, The

    J. Gill, C. Rose, J. Dong, O. Johnston, J. Gill, D. Landsberg

  • Impact of Pancreas Transplantation on 10-Year Cardiovascular Disease Risk in Type 1 Diabetics Requiring Kidney Transplantation, The

    A. Jiang, N. Rowe, T. McGregor, C. Weernink, A. Sener, P. Luke

  • Impact of Post-Donation Body Weight Changes on Kidney Donor Blood Pressure, Kidney Function and Metabolic Parameters

    E. Heaphy, Y. Ohashi, B. Stephany, S. Nurko, R. Fatica, H. Amer, A. Rule, J. Schold, E. Poggio

  • Impact of Pre-Existing and New Onset Diabetes on Hepatitis C Recurrence Following Liver Transplant, The

    K. Morbitzer, D. Taber, J. Fleming, N. Pilch, H. Meadows, C. Jordan, C. Makowski, A. Mardis, C. Bratton, P. Baliga, K. Chavin, J. McGillicuddy

  • Impact of Pre-Transplant Amputation on Renal Allograft Outcomes

    A. Brar, R. Jindal, Z. Mondal, F. Tedla, N. Sumrani, D. John, M. Salifu

  • Impact of Pre-Transplant Donor Renal Function on Graft Survival Following Kidney Transplantation

    W. Irish, M. Corral, K. Ravindra, D. Sudan, B. Kreter, H. Hebden

  • Impact of Proposed US Public Health Service Guidelines for Increased Risk Organ Donors: A Single OPO Analysis

    M. Ison, E. Schultz, M. Jendrisak

  • Impact of Prospective Monitoring for Donor Specific Antibodies on Renal Transplant Outcomes with Alemtuzumab Induction

    V. Saini, V. Mudunuri, S. Cohn, G. Reddy, V. Raofi, L. Rocher, A. Koffron, R. Parasuraman, D. Samarapungavan

  • Impact of Recipient BMI: Implications for ECD Renal Transplantation

    K. Ravindra, W. Irish, D. Vikraman, A. Castleberry, A. Barbas, S. Sanoff, U. Patel, M. Ellis, D. Sudan

  • Impact of Recipient Body Mass Index in Short and Long Term Survival of Pancreatic Grafts

    B. Bédat, N. Niclauss, A. Andres, A. Jannot, C. Toso, P. Morel, T. Berney

  • Impact of Renal Replacement Therapy Following Adult Living Donor Liver Transplantation, The

    H. Iwata, S. Mizuno, E. Ishikawa, A. Tanemura, N. Kuriyama, I. Ohsawa, Y. Azumi, M. Kishiwada, M. Usui, H. Sakurai, M. Tabata, M. Ito, S. Isaji

  • Impact of Repeat Testing of Living Organ Donors after Implementation of a Protocol To Repeat Testing within 14 Days of the Transplant Procedure: A Multi-Center Retrospective Survey

    I. Echenique, D. Cohen, D. LaPointe Rudow, M. Ison

  • Impact of Rural Residence on Accessibility to Liver Transplant and Long-Term Outcomes

    M. Marquez, A. Morillo, J. Seal, M. Selzner, E. Renner, I. McGilvray

  • Impact of Sarcopenia on Survival in Patients Undergoing Living Donor Liver Transplantation

    T. Kaido, K. Ogawa, Y. Fujimoto, T. Ito, K. Tomiyama, A. Mori, Y. Ogura, S. Uemoto

  • Impact of Sarcopenia, Adiposity, and Malnutrition on Liver Transplant Outcomes in the Elderly

    H. Underwood, R. Mangus, J. Fridell, R. Vianna, C. Kubal, S. Garg, A. Tector

  • Impact of Seasonal Influenza Immunization (Influenza+ H1N1) on HLA Antibodies and Kidney Allograft Function

    M. Mujtaba, M. Urabi, A. Sanjiv, A. Sharfuddin, N. Higgins, S. Faiz, M. Yaqub, D. Mishler, A. Lobashevsky, T. Taber

  • Impact of Six Months Ciprofloxacin Prophylaxis on BK Viremia and BK Nephropathy, The

    M. Jason, W. Manitpisitkul, N. Wilson, J. Bromberg, S. Barlett, A. Haririan

  • Impact of Socio-Demographic Variables on the Pathology on Living Kidney Donors

    R. Diaz Wong, B. Acevedo, J. Gaynor, J. Sageshima, L. Chen, A. Mattiazzi, W. Kupin, D. Roth, P. Ruiz, G. Burke, G. Ciancio, G. Guerra

  • Impact of Tacrolimus (FK) Level on Evolution of Graft Function in the First Year after Kidney Transplant (KT) among Recipients with DGF: A Ten Year Retrospective Analysis

    A. Santos, X. Wen, M. Casey, I. Zendejas, C. Bucci, S. Rehman

  • Impact of the Determination of HLA Antibodies in Kidney Transplant over Ten Years of Monitoring

    J. Apaza, E. Gonzalez, E. Gutierrez, A. Andres, N. Polanco, I. Bengoa, L. Garcia Puente, M. Molina, J. Morales

  • Impact of the Revised Lung Allocation Score on Heart-Lung Candidates

    M. Skeans, B. Heubner, M. Hertz, A. Israni, M. Valapour

  • Impact of Transplant Guardian Angels on the Patient Experience, The

    D. Maurer, J. Sherer, R. Shapiro

  • Impact of Type I and Type II Diabetes on BK Nephropathy and Pancreas Transplant Outcomes, The

    C. Bratton, V. Rohan, J. McGillicuddy, A. Lin, K. Chavin, H. Barrier, N. Pilch, P. Baliga, D. Taber

  • Impact of Vitamin D, Bisphosphonate, and Combination Therapy on Bone Mineral Density in Kidney Transplant Patients

    H. Jeon, M. Han, J. Jeong, Y. Kim, H. Kwon, T. Koo, M. Kim, H. Ro, C. Ahn, J. Yang

  • Impact of Waitlist Body Mass Index Changes on the Outcome after Liver Transplantation, The

    L. Orci, P. Majno, T. Berney, P. Morel, G. Mentha, C. Toso

  • Impaired Effector/Memory CD8+ T Cell Response Delays Acute Allograft Rejection in Older Recipients

    A. Elkhal, D. Bedi, C. Denecke, A. Jurisch, I. Kim, T. Heinbokel, H. Li, X. Yuan, X. Ge, S. Tullius

  • Impaired Selectin-Dependent Leukocyte Trafficking Induces T-Cell Exhaustion and Prevents Chronic Allograft Vasculopathy and Rejection

    B. Sarraj, J. Ye, Z. Zheng, S. Miller, G. Kansas, M. Ansari

  • Implementation of a Simplified Method of Islet Isolation To Facilitate Allogeneic Islet Transplantation in Cynomolgus Monkeys

    M. Qi, Y. Wang, K. Formo, E. Marchese, S. Wang, J. McGarrigle, M. Bochenek, K. Kinzer, P. Sanchez, M. Davis, S. Ahn, A. Bartholomew, E. Benedetti, J. Oberholzer

  • Implications of the Statewide Sharing Variance on Kidney Transplantation Geographic Inequity and Allocation Efficiency

    A. Davis, S. Mehrotra, L. McElroy, J. Friedewald, D. Ladner

  • Importance of MDR1 Gene Polymorphisms for Calcineurin Inhibitors Dosage and Early Kidney Graft Function, The

    M. Kravljaca, V. Pravica, E. Savic, V. Brkovic, V. Lezaic, R. Naumovic

  • Improved Bioavailability of MELTDOSE Once-Daily Formulation of Tacrolimus (LCP-Tacro) with Controlled Agglomeration Allows for Consistent Absorption over 24 Hrs: A Scintigraphic and Pharmacokinetic Evaluation

    V. Nigro, A. Glicklich, J. Weinberg

  • Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: 5 Years Follow-Up of the ZEUS Trial

    K. Budde, O. Witzke, C. Sommerer, P. Reinke, U. Eisenberger, E. Paulus, M. Porstner, C. May, W. Arns, F. Lehner

  • Improvements in Living Versus Cadaveric Donor Intestinal Transplantation for Intestinal Failure: The Japanese Experience

    T. Ueno, M. Wada, K. Hoshino, S. Uemoto, T. Taguchi, H. Furukawa, M. Fukuzawa

  • Improving Pancreatic Islet Engraftment through Manipulation of Their Size

    D. Zorzi, T. Phan, D. Freeman, L. Cicalese, C. Rastellini

  • Improving the SRTR Methodology Used To Identify Potentially Underperforming Transplant Programs in the United States

    N. Salkowski, E. Edwards, T. Leighton, A. Israni, B. Kasiske, J. Snyder

  • Improving Value after Pediatric Liver Transplant: Discharge Practices of High-Performing Centers

    B. Kelly, M. Englesbe, J. Bucuvalas, W. Andrews, J. Mitchell, R. Anand, W. Yin, J. Magee, G. Mazariegos, S. Horslen

  • In Situ Quantification of 1,3-Galactosyl Transferase Knockout Swine Liver Protein Production Using Quantitative Comparative ELISA

    M. Hertl, I. Wamala, J. Fraser, Z. Machaidze, C. Schuetz, N. Elias, M. Varma, K. Kim, B. Cosimi, J. Markmann, D. Sachs

  • In Vitro Characterization of Vertebral Bone Marrow Used for Immunomodulation in Hand Transplantation

    N. Yuan, K. Sarkar, M. Lemas, J. Bitzan, J. Sproul, W. Lee, G. Brandacher, D. Cooney

  • In Vitro Differentiation of Naïve/Memory B Cells into Plasma Cells: Difference in Mode of Drug Action between Mycophenolic Acid and Everolimus

    M. Haneda, M. Owaki, K. Iwasaki, Y. Miwa, Y. Watarai, K. Uchida, T. Kobayashi

  • In Vivo Depletion of CD8+ and αβTCR+ Cells Overcomes the Rejection of Vascularized Composite Tissue Allotransplant in Sensitized Recipients

    H. Xu, B. Chen, D. Corbin, S. Ildstad

  • In Vivo IL-2 Administration Can Abrogate Tolerance to Kidney Allografts Induced Via Mixed Chimerism in Non-Human Primates

    Y. Yamada, S. Boskovic, S. Lee, O. Nadazdin, R. Smith, R. Colvin, J. Madsen, D. Sachs, A. Cosimi, T. Kawai, G. Benichou

  • In Vivo Interaction between ATG and IVIg May Decrease the Efficacy of Antibody Mediated Rejection Treatment

    C. Kuriakose, P. Warner, K. Nelson, N. Kieran, R. Bakthavatsalam, C. Davis, N. Leca

  • In-Vivo Persistence, Trafficking and Phenotypic Stability of Autologous, Ex-Vivo Expanded Rhesus Macaque Natural Regulatory T Cells

    K. Singh, L. Stempora, A. Garrett, A. Kirk, C. Larsen, B. Blazar, L. Kean

  • Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis

    C. Liang, O. Famure, Y. Li, J. Kim

  • Incidence of BKV after Kidney Transplantation with Tacrolimus (FK) Based Immunosuppression and Alemtuzumab Induction: A Retrospective Analysis of Donation after-Cardiac Death (DCD) vs. Donation after Brain Death (DBD)

    H. Lam, S. Li, V. Gunabushanam, A. Tevar, H. Tan, A. Basu, M. Sturdevant, A. Humar, J. McCauley, C. Wu, N. Shah, P. Sood, P. Randhawa, A. Zeevis, J. Lunz, R. Shapiro

  • Incidence of CMV Disease in High-Risk Liver Transplant Recipients on Low Dose Valganciclovir Prophylaxis

    S. Tischer, J. Park, L. Stuckey, D. Kaul, C. Sonnenday, R. Fontana

  • Incidence of CMV Infection Comparing Two Antiviral Preventative Strategies after Liver Transplantation

    J. Hagopian, T. Horwedel, W. Chapman, L. Bowman

  • Incidence of Iron Deficiency in Kidney Transplant Candidates Based on the Updated KDIGO Guideline for Anemia, The

    C. Truax, S. Lee, N. Kenyon, M. Gillespie, L. Smith, J. Corbett, F. Shihab

  • Incidence of Malignancy after Kidney Transplantation in the New Era of Immunosuppression

    K. Omoto, T. Shimizu, M. Inui, T. Nozaki, D. Toki, H. Ishida, K. Tanabe

  • Incidence of Post Transplant BKV Infection Using Two Different Cut-Offs for BKV IgG Seropositivity

    P. Sood, D. Cronin, C. Johnson, S. Hariharan

  • Incidence of Subclinical Rejection and De Novo Donor Specific Antibodies in Calcineurin Sparing Regimens

    T. Sandes-Freitas, C. Felipe, E. Campos, M. Soares, H. Tedesco, M. Franco, J. Medina-Pestana

  • Incidence, Risk Factors and Outcomes of BK Viremia and Nephropathy Following Kidney, Simultaneous Kidney-Pancreas or Pancreas after Kidney Transplant

    J. Descourouez, D. Hager, G. Leverson, R. Hofmann, A. Djamali, J. Bellingham, J. Odorico, H. Sollinger, J. Pirsch

  • Incidence, Risk Factors, and Response Rate to Initial Therapy for Clostridum Difficile in Solid Organ Transplant Recipients

    M. Wheeler, J. Deyo, J. Huang, R. Lee, T. Kozlowski, R. Dupuis

  • Incisional Hernia after Liver Transplantation: Incidence and Risk Factors

    S. Zhou, D. Pagano, D. Cintorino, S. Li Petri, C. Ricotta, A. Fratti, M. Paci, F. Tuzzolino, M. Spada

  • Incorporating a Vascularized Composite Allograft Transplant Program into a Transplant Center

    L. Irwin, C. Cetrulo, J. Winograd, A. Marquez, S. Noska, A. Israelian, H. Parker, A. Norman, J. Fishman

  • Incorporating Time from Donation (TFD) to the MDRD and CKD-EPI Formulas Enhances Their Performance in Kidney Donors

    H. Ibrahim, S. Jackson, A. Matas, N. Issa, R. Spong, A. Kukla

  • Increased Duration of Dual Pegylated Interferon and Ribavirin Therapy for Genotype 1 Hepatitis C Post-Liver Transplantation Increases Sustained Virologic Response: A Retrospective Review

    M. Wells, P. Marotta, M. Levstik, N. Chandok, L. Roth, V. Bain, A. Mason, B. Aljudaibi

  • Increased Expression of CTLA-4 and PD-1 and Restricted Functionality as Typical Features of Varizella Zoster Specific T Cells in Patients with Acute Herpes Zoster

    D. Schub, E. Janssen, U. Sester, M. Sester, T. Schmidt

  • Increased Gene Transcripts Related to Immune Activation in Allografts but Not in Peripheral Blood of Patients with Donor-Specific Anti-HLA Antibodies Despite Lack of Histopathologic Findings of Rejection

    N. Hayde, Y. Bao, J. Pullman, G. De Boccardo, M. Lubetzky, E. Akalin

  • Increased Incidence of Non Anastomotic Biliary Strictures in Case of Donation after Circulatory Death Versus Donation after Brain Death Liver Transplantation but Equivalent Graft and Patient Survival

    N. Meurisse, S. Vanden Bussche, I. Jochmans, V. Heedfeld, R. Aerts, W. Laleman, S. Van der Merwe, C. Verslype, D. Cassiman, W. Van Steenbergen, F. Nevens, J. Pirenne, D. Monbaliu

  • Increased Risk of Breakthrough Infection among Cytomegalovirus Donor Positive/Recipient Negative Kidney Transplant Recipients Receiving Lower Dose Valganciclovir Prophylaxis

    D. Stevens, J. Trofe-Clark, E. Blumberg, M. Wilck, B. Weikert, S. Goral, M. Bleicher, D. Sawinski, P. Abt, M. Levine, P. Porrett, R. Bloom

  • Increasing HLA DR Mismatches Is Associated with Inferior Kidney Allograft Outcome in Low Immune Risk Living Donor Kidney Transplant Recipients

    S. Lynch, K. Tinckam, J. Kim

  • Increasing Living Donor (LD) Kidney Transplants by Streamlining the Evaluation Process

    Z. Tulu, M. James, L. Kearns, T. Kozlowski

  • Increasing Resistance in Gramnegative Bacilli Causing Urinary Tract Infection (UTI) in Two Cohorts of Kidney Transplant (KT) Recipients: An Emerging Problem

    J. Origüen, F. López-Medrano, A. Pérez-Jacoiste, A. García-Reyne, N. Carrasco, M. Orellana, A. Andrés, J. Morales, J. Aguado

  • Increasing the Accuracy of Mycophenolic Acid Exposure Estimation in Heart Transplants Using 3 Predictive Tools

    J. Woillard, A. Prémaud, R. Youdarene, A. Rousseau, J. Debord, G. Sinnasse-Raymond, P. Marquet, F. Saint-Marcoux

  • Increasing Utilization of Older Deceased Donors as an Effective Way To Improve Organ Donation Rates: An International Perspective

    B. Lovasik, R. Valero, D. Ladner, G. Pàez, D. Paredes, M. Manyalich

  • Independent Risk Factors Associated with Early Urinary Tract Infection and Its Impact on Bacteremia and Acute Cellular Rejection in 1166 Kidney Transplant Recipients

    J. Lee, H. Bang, D. Dadhania, C. Hartono, M. Aull, M. Suthanthiran, T. Muthukumar

  • Indirect CD4 T Cell Allorecognition of MHC Class II Alloantigen Is Limited by Adaptive Immunity

    J. Ali, T. Conlon, M. Negus, E. Bolton, J. Bradley, K. Saeb-Parsy, G. Pettigrew

  • Indoleamine 2, 3-Dioxygenase Inhibition Alters Noncoding RNAs Following Ischemia-Reperfusion Injury of the Kidney

    T. Merchen, E. Boesen, R. Harbarger, A. Ghaffari, A. Mellor, J. Wynn, R. Podolsky, D. Pollock, N. Nahman Jr

  • Induced Pluripotent Stem Cells from Familial Amyloidotic Polyneuropathy Patients

    K. Isono, H. Jono, Y. Ohya, N. Shiraki, A. Sugasaki, T. Era, N. Fusaki, M. Tasaki, M. Ueda, S. Shinriki, Y. Inomata, S. Kume, Y. Ando

  • Induction Immunosuppression and Subclinical Viremia in Pediatric Renal Transplantation

    J. Smith, S. Gantt, A. Dick, P. Healey, T. Nemeth, R. McDonald

  • Induction of Donor Specific Hyporesponsiveness in Kidney Transplantation Using Adoptive Transfer of Ex Vivo Induced Tolerogenic Cells

    I. Koyama, H. Bashuda, K. Seino, K. Kai, T. Murakami, A. Sannomiya, I. Nakajima, S. Fuchinoue, K. Okumura, S. Teraoka

  • Inequitable Access to Deceased Donor Kidney Transplantation (KTx) in a State with Multiple Donor Service Areas (DSAs)

    R. Lewis, A. Sankar, J. Pittman

  • Infection Related Kidney Discards

    L. Malinzak, A. Patel, D. Kim, J. Denny, M. Weitzer, G. Alangaden, M. Ramesh

  • Infectious Complications after Depleting or Non-Depleting Antibody Induction in Kidney Transplant Recipients over 60 Years of Age

    S. Patel, J. DeVos, K. Dawson, R. Knight, A. Gaber

  • Infectious Disease Screening of Living Kidney and Liver Donors at a Large Transplant Center

    J. Kim, C. Freise, P. Chin-Hong

  • Inflammatory Bowel Disease in Renal Transplant Recipients: A Retrospective Multicenter Study

    A. Fournier, C. Barbet, O. Toupance, I. Etienne, B. Hurault de Ligny, Y. Lemeur, J. Rerolle, S. Ohlmann, A. Tiple, D. Anglicheau, G. Touchard, E. Thervet, J. Rivalan, Y. Lebranchu, M. Büchler

  • Inflammatory Milieu in (d-AIH) Reduces Regulatory T-Cell Function, The

    U. Ekong, B. Scher, H. Melin-Aldana, K. Amsden, M. O'Gorman

  • Influence of Baseline Immunosuppresion on Renal Function and Clinical Outcomes in Liver Transplantation, The

    A. Mardis, D. Taber, H. Meadows, N. Pilch, J. Fleming, C. Jordan, K. Morbitzer, C. Makowski, J. McGillicuddy, C. Bratton, K. Chavin, P. Baliga

  • Influence of Carbon Monoxide-Releasing Molecule-3 Treatment on Dendritic Cell Maturation and Infiltration

    T. Sun, J. Arp, M. Selna, Z. Lan, W. Min, A. Sener, A. Jevnikar, P. Luke

  • Influence of Donor’s and Recipent’s CMV Serostatus on the Allograft Survival and CD8 Cell Compartment Evolution in Kidney Transplant Recipient: A Monocentric Cohort Study

    P. Gatault, J. Halimi, C. Barbet, G. Thibault, A. Goudeau, Y. Lebranchu, M. Büchler, C. Baron

  • Influence of Ginseng Treatment on Immune Response and Autophagic Cell Death in Cyclosporine-Based Immunesuppression

    S. Lim, K. Doh, L. Jin, S. Piao, S. Heo, B. Chung, M. Cho, C. Yang

  • Influence of HLA Class II Donor-Specific Antibodies Present at the Time of Renal Transplantation on Early Graft Outcome, The

    C. Bryan, A. Gupta, D. Murillo, C. Wang, S. Yarlagadda, A. Nawabi, T. Schmitt

  • Influence of Organ Retrieval Team on Mid-Term Outcome of Lung Transplantation

    D. García Sáez, A. Sabashnikov, B. Zych, P. Mohite, A. Moza, F. De Robertis, T. Bahrami, M. Amrani, M. Carby, A. Reed, A. Simon

  • Influence of Plasmapheresis on the Concentration of Soluble Urokinase Receptor (suPAR) in Patients with Focal Segmental Glomerulosclerosis (FSGS)

    O. Staeck, D. Khadzhynov, F. Halleck, M. Duerr, M. Naik, L. Liefeld, I. Lieker, T. Slowinski, H. Peters, H. Neumayer, K. Budde

  • Influence of Preoperative Anti-HLA Antibodies on Short-Term and Long-Term Graft Survival in Recipients with or without Rituximab Treatment

    H. Ishida, T. Shimizu, M. Furusawa, K. Omoto, M. Inui, T. Nozaki, K. Tanabe

  • Influence of Recipient Age on Outcomes in Paired Kidney Transplantation

    U. Farooq, Y. Al-Shraideh, G. Orlando, J. Rogers, A. Farney, R. Stratta

  • Influence of Recipient Cytochrome P450 3A5 Polymorphism on the Metabolism of Advagraf Administered De Novo after Renal Transplantation

    M. De Meyer, V. Haufroid, N. Kanaan, L. De Pauw, D. Chaib Eddour, M. Mourad

  • Influence of SLCO1B1 and SLCO2B1 Polymorphisms on Tacrolimus Pharmacokinetics and Clinical Efficacy and Safety

    C. Alves, C. Felipe, A. Nishikawa, P. Salgado, C. Fajardo, G. Spinelli, H. Tedesco, J. Medina- Pestana, M. Hirata, R. Hirata, A. Rodrigues

  • Influence of Steroid Maintenance on the Outcomes in Sensitized Kidney Transplant Recipients

    K. Sureshkumar, K. Nashar, S. Hussain, T. Ko, N. Thai, P. Abrams, R. Marcus

  • Influenza Vaccination and Humoral Alloimmunity in Solid Organ Transplant Recipients

    P. Vermeiren, V. Aubert, R. Sugamele, J. Aubert, J. Venetz, P. Meylan, M. Pascual, O. Manuel

  • Inherited Patients: Friend or Foe?

    H. Hoy

  • Inhibition of IL-6/IL-6R Interactions by Anti-IL-6R Monoclonal Antibody Suppresses Donor Specific Antibody Responses in a Mouse Model of HLA Sensitization

    S. Jordan, G. Wu, N. Chai, I. Kim, A. Klein

  • Inhibition of IL6 Mediated Th17 Differentiation Via BATF Signaling Prevents the Development of Obliterative Airway Disease Induced by Antibodies to MHC Molecules

    S. Ramachandran, V. Subramanian, A. Gelman, T. Mohanakumar

  • Inhibition of Receptor Interacting Protein 3 (RIP3) Promotes Long Term Renal Allograft Survival

    A. Lau, S. Wang, A. Haig, Z. Yin, Z. Zhang, A. Jevnikar

  • Injected Allogeneic CD4+CD25+ Tregs Regulate the Neonatal Immune System and Prolong Heart Allograft Survival

    R. Bascom, K. Tao, S. Tollenaar, L. West

  • Insulin-Like Growth Factor-II (IGF-II) Prevents Pro-Inflammatory Cytokine Induced Apoptosis and Significantly Improves Islet Survival Post-Transplantation

    A. Hughes, D. Mohanasundaram, S. Kireta, C. Jessup, C. Drogemuller, P. Coates

  • Integrated Analysis of MHC Class I-Like (MICA, HLA-E and EPCR) Genetic Diversity in Kidney Transplant Donors and Graft’s Endothelial Cell Phenotype

    B. Charreau, N. Gerard, P. Tonnerre, P. Gavlovsky, A. Pabois, C. Guitton

  • Integrative Genomic Approach for Identifying Early Biomarkers of Hepatitis C-Related Hepatocellular Carcinoma

    D. Maluf, R. Gehrau, J. Suh, K. Archer, V. Mas

  • Intended and Unintended Consequences of Share 35

    C. Chesley, W. Parker, L. Ross, J. Thistlethwaite, Jr

  • Interactions of B and T Regulatory Cells in Normal Volunteers and in Tolerant HLA-Identical Kidney Transplant Recipients

    J. Mathew, J. Leventhal, X. Huang, L. Chen, A. Tambur, J. Friedewald, M. Abecassis, J. Miller

  • Interactive Web-Based Patient Portal for the Evaluation of Potential Kidney Transplant Recipients

    A. Webber, S. Tomlanovich, M. Parente, J. Roberts, R. Hirose

  • Interception CD40/CD40L Aisle Induce Homogeneity Transplantation Immunity Immunotolerance Study

    X. Ding, X. Wang, Y. Li, W. Xue, X. Tian

  • Interim Analysis of a Double-Blinded Placebo Controlled Trial of IVIG v. IVIG + Rituximab for Desensitization of Highly-HLA Sensitized (PRA >80%) (HS) Deceased Donor (DD) Candidates

    A. Vo, J. Choi, M. Lukovsky, M. Toyoda, S. Ge, J. Kahwaji, A. Peng, R. Villicana, R. Najjar, S. Jordan

  • Interleukin-1 Receptor Antagonist Delays Progression of Liver Fibrosis

    R. Meier, Y. Muller, S. Lacotte, G. Mentha, P. Morel, C. Gonelle-Gispert, L. Buhler

  • Internet Use among Kidney Transplant Candidates

    C. Mewaldt, A. Disharoon, A. Skaro, J. Caicedo, E. Gordon

  • Interplay between mTOR and STAT5 Signaling Modulates the Balance between Regulatory and Effective T Cells

    J. Shan, L. Feng, Y. Li

  • Interpreting Macrophage Transcripts in T Cell-Mediated Rejection in Humans

    D. Badr, L. Hidalgo, K. Famulski, P. Halloran

  • Intra-Graft Expression of Transcripts for Endothelial Activation and NK Cell Markers, Detected by Real-Time qPCR, Is Associated with the Presence of Donor Specific Antibodies, and Identifies Kidney Transplants at Risk of Failure

    A. McLean, K. Dominy, H. De Kort, P. Brookes, J. Behmoaras, J. Galliford, C. Roufosse, T. Cook, M. Willicombe, D. Taube

  • Intracoronary Treatment with VEGF-C/D Inhibitor Enhances Cardiac Allograft Survival and Prevents Chronic Rejection by Regulating Lymphatic Endothelial Cell Activation

    A. Dashkevich, S. Syrjälä, M. Keränen, R. Tuuminen, R. Krebs, N. Antti, K. Alitalo, K. Lemström

  • Intragraft CD11c+ Dendritic Cells Trigger the More Potent IL-17 Mediated Immune Response When Transplanting Older Organs

    R. Oberhuber, T. Heinbokel, O. Boenisch, H. Karin, A. ElKahl, J. Pratschke, S. Tullius

  • Intragraft Gene Expression of Polyomavirus Associated Nephropathy

    M. Naesens, T. Sigdel, N. Salomonis, S. Roedder, X. Gao, M. Vitalone, D. Kuypers, E. Lerut, M. Sarwal

  • Intragraft Gene Expression Profiles of C4d-/DSA+ and C4d-/DSA- Transplant Glomerulopathy Biopsies Compared to Biopsies with Chronic Antibody Mediated Rejection

    N. Hayde, Y. Bao, J. Pullman, G. De Boccardo, M. Lubetzky, E. Akalin

  • Intrahepatic Cholangiocarcinoma (I-CC) or Mixed Hepatocellular-Cholangiocarcinoma (HCC-CC) in Patients Undergoing Liver Transplantation (LT). A Spanish Case Control Multicenter Study

    R. Charco, G. Sapisochin, C. Rodriguez-Lope, M. Gastaca, J. Ortiz de Urbina, R. Lopez-Andujar, F. Palacios, E. Ramos, J. Fabregat, J. Castroagudin, E. Varo, J. Pons, P. Parrilla, M. Gonzalez-Dieguez, M. Rodriguez, A. Otero, M. Vazquez, G. Zozaya, J. Herrero, G. Sanchez Antolin, B. Perez, R. Ciria, S. Rufián, Y. Fundora, J. Ferrón, A. Guiberteau, G. Blanco, M. Varona, M. Barrera, M. Suarez, J. Santoyo, J. Bruix

  • Intrahepatic Natural Killer Cells Highly Expressing NKp46 Inhibit Early-Phase Post-Transplant Hepatitis C Virus Replication

    N. Tanimine, Y. Tanaka, H. Ohdan

  • Intraoperative Renal Replacement Therapy during Liver Transplant: Outcomes of 105 Cases

    M. Mai, R. Brotman, H. Wadei, M. Prendergast, K. Oshel, B. Taner, A. Keaveny, T. Gonwa

  • Intraportal Autoislet Cell Transplantation (IAT): Changes in Portal Pressure and Flow and Associated Clinical Outcomes

    T. Dunn, M. Bellin, J. Wilhelm, A. Balamurugan, G. Beilman, S. Chinnakotla, S. Vickers, D. Sutherland, T. Pruett

  • Intravascular Ultrasound (IVUS) Results of a Randomized Trial of Allomap vs Heart Biopsy in the 1st Year after Heart Transplant

    J. Kobashigawa, J. Patel, M. Kittleson, D. Chang, L. Czer, T. Daun, A. Trento, F. Esmailian

  • Intravital Two-Photon Imaging of Neutrophil Recruitment Reveals an Efficacy of FPR1 Blockade To Attenuate the Hepatic Ischemia-Reperfusion Injury

    M. Honda, T. Takeichi, K. Asonuma, Y. Inomata

  • Introducing a Reliable Hindlimb Transplantation Model in the Mouse Utilizing Innovative Supermicrosurgical Techniques for Vascular Anastomosis

    J. Grahammer, Q. Mao, S. Schneeberger, R. Sucher, W. Lee, G. Brandacher

  • Invasive Fungal Infection in Liver Transplant Recipients – Focus on Underestimated Risk Factors Associated with In-Hospital Mortality

    I. Göcze, A. Pross, F. Zeman, S. Farkas, M. Scherer, S. Lang, M. Loss, B. Graf, T. Bein, H. Schlitt

  • Iothalamate Urinary Clearance May Be Unreliable: A Comparison to Modification of Diet in Renal Disease in Renal Transplant Patients

    M. Tortorici, H. Li, C. Hahn, A. Flynn, J. Korth-Bradley, S. Schulman

  • IRF-1 Regulates Immune Reactivity in Mouse Hepatic Allografts

    S. Kimura, O. Yoshida, J. Klune, S. Yokota, K. Ozaki, N. Murase, A. Thomson, D. Geller

  • Irradiation and T Cell Depletion Augment Bone Marrow-Derived Chimerism at the Cost of Morbidity and Mortality in a Non-Human Primate Model of Vascularized Composite Allotransplantation

    P. Brazio, J. Ha, R. Munivenkatappa, R. Mohan, E. Rodriguez, S. Bartlett, R. Barth

  • Is Dysfunction of the HNF-1 Beta Gene Involved in the Pathogenesis of New-Onset Diabetes after Transplantation?

    G. van Boekel, M. van den Beukel, B. de Kort, C. Lamper, M. Strik, L. Hilbrands

  • Is Evaluation of Incidental Adrenal Lesions in Living Renal Donors Necessary?

    J. Wang, A. Rastogi, H. Gritsch

  • Is KDPI Accurate in Predicting Outcomes Associated with Utilization of Single Pediatric Donor Kidneys?

    A. Watkins, M. Aull, J. Kim, J. Guerrero, D. Dadhania, S. Kapur

  • Is Liver Transplantation Outcome Worse for HCC Patients Using Organ Donation after Cardiac Death?

    G. El-Gazzaz, K. Hashimoto, C. Quintini, D. Kelly, C. Winans, B. Eghtesad, F. Aucejo, K. Abu-Elmagd, J. Fung, C. Miller

  • Is Micro-RNA-122 (miR-122) an Accurate Biomarker for Ischemia-Reperfusion Injury during Liver Transplantation?

    M. Hughes, S. Reddy, M. Brier, C. McClain, C. Jonsson

  • Is Mycophenolic Acid AUC a Good Pronostic Factor for BK Viremia?

    T. Lamy, B. Hurault de Ligny, J. Dina, D. Debruyne, V. Chatelet, T. Lobbedez, M. Ficheux, N. Bouvier

  • Is the Obesity Epidemic in the United States Driving the Lack of Growth of Live Kidney Donation?

    D. Moore, I. Feurer, L. Dageforde, E. Zavala, D. Moore

  • Is There a Clinically Meaningful Difference between "Preformed" and "De Novo" Alloantibodies in Negative Crossmatch Renal Transplantation?

    M. Everly, L. Rebellato, K. Briley, C. Morgan, P. Bolin, W. Kendrick, S. Kendrick, C. Haisch, R. Harland, P. Terasaki

  • Is There More Stress or Coercion To Donate in KPD Donors?

    D. Serur, M. Charlton, M. Lawton, J. Sinacore, C. Li, J. Gordon-Elliott

  • Is Uric Acid an Independent Risk Factor for Graft Failure in Kidney Transplant Recipients?

    E. Kim, O. Famure, Y. Li, J. Kim

  • Ischemia-Induced ATF6 Upregulation Is a Key Factor in Liver Pro-Inflammatory Immune Response Against Ischemia Reperfusion

    J. Rao, S. Yue, J. Zhu, R. Bussutil, J. Kupiec-Weglinski, L. Lu, Y. Zhai

  • Islet Size Index as a Predictive Indicator of Outcomes in Clinical Islet Autotransplantation

    T. Suszynski, J. Wilhelm, M. Bellin, D. Radosevich, D. Sutherland, G. Beilman, T. Dunn, S. Chinnakotla, T. Pruett, S. Vickers, K. Papas

  • Isolated Liver Transplantation for Pediatric Patients with Intestinal Failure Associated Liver Disease

    E. Island, J. Guerra, E. Hughes, S. Kaufman, R. Girlanda, C. Desai, C. Matsumoto, T. Fishbein

  • Isolation and Hepatocyte Differentiation of Mesenchymal Stem Cells (MSC) from Porcine Bone Marrow – ‘Surgical Waste’ as a Novel MSC Source

    H. Tautenhahn, S. Brückner, S. Pelz, P. Stock, M. Dollinger, B. Christ

Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences